Position as Postdoctoral Research Fellowship is available at Dept. of Pharmacy at the School of Pharmacy, Faculty of Mathematics and Natural Sciences. The fellowship will be for a period of 2 years. Starting date by September 2019 by the latest.
The candidate will be working on the ERC Starting Grant project “Effects of Medication Use in Pregnancy on Infant Neurodevelopment” (DrugsInPregnancy). The background for the project is the lack of knowledge about long term safety of prenatal exposure to medication. The aim of the project is to use causal inference methods to study associations between medication use during pregnancy and possible long-term neurodevelopment disorders in childhood. The epidemiological data consists of data from the Norwegian Mother and Child Cohort (MoBa) at the National Institute of Public Health linked to other national health registries. The project may also include analyses of epigenetic data from individuals from the MoBa-study.
The candidate will become part of the PharmacoEpidemiology and Drug Safety Research Group headed by Professor Nordeng at the School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo. The project will be performed in close collaboration with international partners and partners at the National Institute of Public Health.
The candidate will also be included in the PharmaTox Strategic Research Initiative at the Faculty of Mathematics and Natural Sciences, University of Oslo. PharmaTox is a multidisciplinary center comprising strong research environments in pharmaceutical bioscience, biology, bioinformatics and statistics.
More about us: PharmaSafe: www.mn.uio.no/farmasi/english/research/groups/pharma-safe/index.html PharmaTox: www.mn.uio.no/farmasi/english/research/groups/pharmatox/
Applicants must hold a degree equivalent to a Norwegian doctoral degree in epidemiology. Doctoral dissertation must be submitted for evaluation by the closing date. Appointment is dependent on the public defence of the doctoral thesis being approved. The successful candidate must prove competence in epidemiology, biostatistics and good knowledge of statistical programs (e.g. STATA, R, SAS). The preferred candidate possesses has experience with pharmacology, pharmacoepidemiology and handling large data sets. Interest and experience with interdisciplinary work is an advantage. Fluent oral and written communication skills in English
Internal Number: 1-2018
About University of Oslo
The PharmacoEpidemiology & Drug Safety Research Group covers a wide range of research activities related to optimal use and safety of medication on an individual and societal level. We use epidemiological methods to address questions of drug safety that cannot be studies in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, perception towards medicines, methodology research, analysis of medication safety on patient outcomes and health economics.The research group is multidiciplinary and has expertise in pharmacoepidemiology and drug safety, statistics, health economics and pharmacotherapy.